Drug Discovery 서비스 시장 규모, 점유율, 동향 및 성장 분석 보고서(2026-2034년)

The Drug Discovery Services Market size is expected to reach USD 92.83 Billion in 2034 from USD 26.04 Billion (2025) growing at a CAGR of 15.17% during 2026-2034.

The global drug discovery services market is expanding rapidly due to the increasing demand for new and effective therapeutics across multiple disease areas. Pharmaceutical and biotechnology companies are increasingly outsourcing drug discovery processes to specialized service providers in order to reduce costs and accelerate development timelines. These services include target identification, lead optimization, screening, and preclinical research.

Technological advancements such as artificial intelligence, high-throughput screening, and advanced bioinformatics are transforming the drug discovery process. These technologies enable researchers to analyze large datasets, identify promising drug candidates more efficiently, and reduce the overall time required for drug development. As a result, outsourcing partners with advanced capabilities are gaining significant importance in the pharmaceutical ecosystem.

Future prospects for the drug discovery services market remain strong as the demand for innovative drugs continues to rise. Increasing investments in biotechnology research, expanding pharmaceutical pipelines, and the growing prevalence of chronic diseases are expected to support market growth. Collaboration between pharmaceutical companies and specialized research organizations will further drive expansion in this sector.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Process

• Target Selection
• Target Validation
• Hit-to-lead Identification
• Lead Optimization
• Candidate Validation

By Type

• Chemistry Services
• Biology Services

By Drug Type

• Small Molecule Drugs
• Biologics Drugs

By Therapeutic Area

• Neurology
• Infectious and Immune Systems Diseases
• Digestive System Diseases
• Oncology
• Other Therapeutic Areas

By End User

• Pharmaceutical & Biotechnology Companies
• Academic Institutes
• Manufacturing
• Other End Users

COMPANIES PROFILED

• Laboratory Corporation of America Holdings, Charles River Laboratories International Inc, Thermo Fisher Scientific Inc, Evotec SE, Pharmaron Beijing Co Ltd, Genscript Biotech Corporation, WuXi AppTec, Eurofins Scientific, Syngene International, Curia formerly AMRI, Piramal Pharma Solutions
• We can customise the report as per your requirements.

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL DRUG DISCOVERY SERVICES MARKET: BY PROCESS 2022-2034 (USD MN)

• 4.1. Market Analysis, Insights and Forecast Process
• 4.2. Target Selection Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.3. Target Validation Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.4. Hit-to-lead Identification Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.5. Lead Optimization Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.6. Candidate Validation Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL DRUG DISCOVERY SERVICES MARKET: BY TYPE 2022-2034 (USD MN)

• 5.1. Market Analysis, Insights and Forecast Type
• 5.2. Chemistry Services Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.3. Biology Services Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL DRUG DISCOVERY SERVICES MARKET: BY DRUG TYPE 2022-2034 (USD MN)

• 6.1. Market Analysis, Insights and Forecast Drug Type
• 6.2. Small Molecule Drugs Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.3. Biologics Drugs Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL DRUG DISCOVERY SERVICES MARKET: BY THERAPEUTIC AREA 2022-2034 (USD MN)

• 7.1. Market Analysis, Insights and Forecast Therapeutic Area
• 7.2. Neurology Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.3. Infectious and Immune Systems Diseases Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.4. Digestive System Diseases Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.5. Oncology Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.6. Other Therapeutic Areas Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 8. GLOBAL DRUG DISCOVERY SERVICES MARKET: BY END USER 2022-2034 (USD MN)

• 8.1. Market Analysis, Insights and Forecast End User
• 8.2. Pharmaceutical & Biotechnology Companies Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 8.3. Academic Institutes Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 8.4. Manufacturing Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 8.5. Other End Users Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 9. GLOBAL DRUG DISCOVERY SERVICES MARKET: BY REGION 2022-2034(USD MN)

• 9.1. Regional Outlook
• 9.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 9.2.1 By Process
  • 9.2.2 By Type
  • 9.2.3 By Drug Type
  • 9.2.4 By Therapeutic Area
  • 9.2.5 By End User
  • 9.2.6 United States
  • 9.2.7 Canada
  • 9.2.8 Mexico
• 9.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 9.3.1 By Process
  • 9.3.2 By Type
  • 9.3.3 By Drug Type
  • 9.3.4 By Therapeutic Area
  • 9.3.5 By End User
  • 9.3.6 United Kingdom
  • 9.3.7 France
  • 9.3.8 Germany
  • 9.3.9 Italy
  • 9.3.10 Russia
  • 9.3.11 Rest Of Europe
• 9.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 9.4.1 By Process
  • 9.4.2 By Type
  • 9.4.3 By Drug Type
  • 9.4.4 By Therapeutic Area
  • 9.4.5 By End User
  • 9.4.6 India
  • 9.4.7 Japan
  • 9.4.8 South Korea
  • 9.4.9 Australia
  • 9.4.10 South East Asia
  • 9.4.11 Rest Of Asia Pacific
• 9.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 9.5.1 By Process
  • 9.5.2 By Type
  • 9.5.3 By Drug Type
  • 9.5.4 By Therapeutic Area
  • 9.5.5 By End User
  • 9.5.6 Brazil
  • 9.5.7 Argentina
  • 9.5.8 Peru
  • 9.5.9 Chile
  • 9.5.10 South East Asia
  • 9.5.11 Rest of Latin America
• 9.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 9.6.1 By Process
  • 9.6.2 By Type
  • 9.6.3 By Drug Type
  • 9.6.4 By Therapeutic Area
  • 9.6.5 By End User
  • 9.6.6 Saudi Arabia
  • 9.6.7 UAE
  • 9.6.8 Israel
  • 9.6.9 South Africa
  • 9.6.10 Rest of the Middle East And Africa

Chapter 10. COMPETITIVE LANDSCAPE

• 10.1. Recent Developments
• 10.2. Company Categorization
• 10.3. Supply Chain & Channel Partners (based on availability)
• 10.4. Market Share & Positioning Analysis (based on availability)
• 10.5. Vendor Landscape (based on availability)
• 10.6. Strategy Mapping

Chapter 11. COMPANY PROFILES OF GLOBAL DRUG DISCOVERY SERVICES INDUSTRY

• 11.1. Top Companies Market Share Analysis
• 11.2. Company Profiles
  • 11.2.1 Laboratory Corporation Of America Holdings
  • 11.2.2 Charles River Laboratories International Inc
  • 11.2.3 Thermo Fisher Scientific Inc
  • 11.2.4 Evotec SE
  • 11.2.5 Pharmaron Beijing Co. Ltd
  • 11.2.6 Genscript Biotech Corporation
  • 11.2.7 WuXi AppTec
  • 11.2.8 Eurofins Scientific
  • 11.2.9 Syngene International
  • 11.2.10 Curia (Formerly AMRI)
  • 11.2.11 Piramal Pharma Solutions